Results 121 to 130 of about 99,236 (370)

Relative Frequency of Peptic Ulcer and Erosion in Patients with Different Types of Cholestasis

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2008
Introduction: Cholestasis is impairment of normal bile excretion into the duodenum and classified as mechanical and non mechanical cholestasis. Mechanical Cholestasis presents with increase in bile duct diameter or obstruction in bile duct in an ERCP ...
F Joukar   +4 more
doaj  

Cholestasis syndrome in a comorbid patient: diagnostic difficulties

open access: yesМедицинский совет, 2019
The purpose of the review article is to demonstrate generalized ideas on the classification and diagnosis of cholestasis syndrome of various etiologies, to consider the possibility of using laboratory and instrumental research methods in real clinical ...
E. V. Vinnitskaya   +5 more
doaj   +1 more source

Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ‐glutamyltransferase cholestasis

open access: yesHepatology, 2017
Hereditary cholestasis in childhood and infancy with normal serum gamma‐glutamyltransferase (GGT) activity is linked to several genes. Many patients, however, remain genetically undiagnosed.
Y. Qiu   +19 more
semanticscholar   +1 more source

Screening by high‐throughput sequencing for pathogenic variants in cystic fibrosis: Benefit of introducing personalized therapies

open access: yesJournal of Cellular and Molecular Medicine, Volume 26, Issue 23, Page 5943-5947, December 2022., 2022
Abstract This short report documented cystic fibrosis transmembrane conductance regulator (CFTR) variants in 37 patients with cystic fibrosis (CF) in the Rio Grande do Norte region of Northeast Brazil. The high‐throughput sequencing technology (HTS) genetic testing provided a definitive molecular diagnosis in 31 patients (83.8%).
Ana Cristina Vieira de Melo   +6 more
wiley   +1 more source

THREE CASES WITH BURKITT LYMPHOMA PRESENTING WITH CHOLESTASIS

open access: yesHematology, Transfusion and Cell Therapy, 2021
Case report: Cholestasis secondary to neoplasm is rare in children. It is also rare in Burkitt lymphoma and may be cause to treatment delay. We report 3 cases diagnosed with Burkitt lymphoma with cholestasis.
Fatma Tuba YILDIRIM   +6 more
doaj  

Dose-related liver injury of Geniposide associated with the alteration in bile acid synthesis and transportation. [PDF]

open access: yes, 2017
Fructus Gardenia (FG), containing the major active constituent Geniposide, is widely used in China for medicinal purposes. Currently, clinical reports of FG toxicity have not been published, however, animal studies have shown FG or Geniposide can cause ...
Feng, Xiaoyi   +17 more
core   +2 more sources

Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis

open access: yesNature Communications, 2018
In infants intolerant of enteral feeding because of intestinal disease, parenteral nutrition may be associated with cholestasis, which can progress to end-stage liver disease.
K. E. El Kasmi   +17 more
semanticscholar   +1 more source

Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse [PDF]

open access: yes, 2017
Tartrazine is a food colour that activates the transcriptional function of the human oestrogen receptor alpha in an in vitro cell model. Since oestrogens are cholestatic, we hypothesised tartrazine will cause periportal injury to the liver in vivo.
Axon, Andrew R.   +9 more
core   +2 more sources

MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease

open access: yesHepatology, 2017
Some patients with microvillus inclusion disease due to myosin 5B (MYO5B) mutations may develop cholestasis characterized by a progressive familial intrahepatic cholestasis‐like phenotype with normal serum gamma‐glutamyl transferase activity.
E. Gonzales   +7 more
semanticscholar   +1 more source

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]

open access: yes, 2007
Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Boeck, Stefan   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy